CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|||||||||
| Revenues | ||||||||||||
| Total revenues | $ 977,657 | $ 667,064 | $ 2,761,439 | $ 1,845,381 | ||||||||
| Expenses | ||||||||||||
| Cost of sales | 623,821 | 362,922 | 1,783,871 | 980,894 | ||||||||
| Operating expenses | 62,327 | 39,092 | 175,434 | 105,858 | ||||||||
| Research and development | 22,014 | 0 | 41,461 | 0 | ||||||||
| General and administrative | 2,305 | 1,829 | 6,963 | 7,387 | ||||||||
| Acquisition and transaction expenses | 5,030 | 7,066 | 27,090 | 18,847 | ||||||||
| Depreciation and amortization | 43,295 | 55,278 | 142,570 | 170,076 | ||||||||
| Total expenses | 758,792 | 466,187 | 2,177,389 | 1,283,062 | ||||||||
| Other (expense) income | ||||||||||||
| Interest expense | (65,119) | (60,784) | (190,628) | (186,789) | ||||||||
| Equity in earnings (losses) of unconsolidated entities | [1] | 16,933 | (4,224) | 24,540 | [2] | (16,841) | [2] | |||||
| Other income | 2,168 | 3,570 | 57,324 | 63,797 | ||||||||
| Total other expense | (46,018) | (56,829) | (91,131) | (89,750) | ||||||||
| Income before income taxes | 172,847 | 144,048 | 492,919 | 472,569 | ||||||||
| Provision for income taxes | 22,239 | 26,330 | 79,318 | 87,067 | ||||||||
| Net income | 150,608 | 117,718 | 413,601 | 385,502 | ||||||||
| Less: Dividends on preferred shares | 1,544 | 3,709 | 8,962 | 13,533 | ||||||||
| Less: Loss on redemption of preferred shares | 0 | 0 | 3,800 | 6,327 | ||||||||
| Net income attributable to shareholders | $ 149,064 | $ 114,009 | $ 400,839 | $ 365,642 | ||||||||
| Earnings per share: | ||||||||||||
| Basic (in dollars per share) | $ 1.45 | $ 1.11 | $ 3.91 | $ 3.57 | ||||||||
| Diluted (in dollars per share) | $ 1.43 | $ 1.10 | $ 3.85 | $ 3.52 | ||||||||
| Weighted average shares outstanding: | ||||||||||||
| Basic (in shares) | 102,667,105 | 102,569,415 | 102,613,229 | 102,560,285 | ||||||||
| Diluted (in shares) | 104,106,460 | 103,966,650 | 104,059,963 | 103,951,713 | ||||||||
| Equity Method Investee | ||||||||||||
| Other (expense) income | ||||||||||||
| Gain on sale to the 2025 Partnership - affiliate | $ 0 | $ 4,609 | $ 17,633 | $ 50,083 | ||||||||
| Aerospace products revenue | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 780,598 | 459,206 | 1,995,412 | 1,144,317 | ||||||||
| MRE Contract revenue | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 129,408 | 58,663 | 533,437 | 228,886 | ||||||||
| Lease income | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 25,281 | 55,072 | 92,938 | 185,951 | ||||||||
| Maintenance revenue | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 27,292 | 52,370 | 83,684 | 175,081 | ||||||||
| Asset sales revenue | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 5,886 | 38,461 | 32,995 | 105,315 | ||||||||
| Other revenue | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | [3] | $ 9,192 | $ 3,292 | $ 22,973 | $ 5,831 | |||||||
| ||||||||||||
| X | ||||||||||
- Definition Weighted Average Shares Outstanding [Abstract] No definition available.
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|